Medline to report fourth quarter and full year 2025 results on February 25, 2026
Rhea-AI Summary
Medline (Nasdaq: MDLN) will report fourth quarter and full year 2025 results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before market open, followed by a webcast and conference call at 9:30am ET / 8:30am CT.
Investors can access the live webcast and replay on Medline's Events page at ir.medline.com.
Positive
- None.
Negative
- None.
News Market Reaction – MDLN
On the day this news was published, MDLN declined 4.30%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
No peer stocks were flagged in momentum scanners, suggesting the 3.28% move is stock-specific rather than part of a sector-wide shift.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 30 | Conference participation | Neutral | +0.2% | Announcement of J.P. Morgan Healthcare Conference presentation and webcast access. |
| Dec 18 | IPO and offering | Neutral | -3.7% | Closing of upsized IPO and full exercise of underwriters’ option. |
With limited post-IPO history, Medline’s news flow has so far produced modest price moves around corporate and capital markets events.
In the last month, Medline’s key disclosures centered on capital markets and investor outreach. The upsized IPO and underwriters’ option closing on Dec 18, 2025 coincided with a -3.66% move, while the J.P. Morgan Healthcare Conference participation announcement on Dec 30, 2025 saw a mild 0.19% reaction. Today’s earnings date notice fits this pattern of early-stage public-company communication and adds timing for its first full-year results as a public issuer.
Market Pulse Summary
This announcement sets February 25, 2026 as the date for Medline’s fourth quarter and full year 2025 results, with a webcast at 9:30am ET. As a recently public company, prior news has focused on its IPO and investor events. Investors may watch this first full-year report for revenue trends, profitability, and guidance, comparing outcomes to expectations formed since the December 2025 IPO.
AI-generated analysis. Not financial advice.
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.
Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website.
About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Contacts
Investor Relations:
Karen King
Global Head of Investor Relations
Patrick Flaherty
Director, Investor Relations
(847) 247-7222
IR@medline.com
Media Relations:
Ben Fox
Vice President, Corporate Communications
(224) 327-9999
media@medline.com
Source: Medline Inc.